Method and detection kit for identifying biomarker of cerebral hemorrhage

A technology of biomarkers and kits, applied in the field of medicine, can solve the problems of unsuitability for routine purposes, large amount of serum samples, and expensive instruments, and achieve the effects of simplified operation, short analysis time, and reasonable price of instruments.

Inactive Publication Date: 2019-02-15
THE AFFILIATED HOSPITAL OF QINGDAO UNIV
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For example, when using enzymatic method, gas-liquid chromatography and high-resolution liquid chromatography, in order to avoid the influence of high-concentration glucose, it needs to be removed, resulting in cumbersome pretreatment process; gas-liquid chromatography-mass spectrometry instruments

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method and detection kit for identifying biomarker of cerebral hemorrhage
  • Method and detection kit for identifying biomarker of cerebral hemorrhage
  • Method and detection kit for identifying biomarker of cerebral hemorrhage

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0051] Example 1

[0052] (1) Precisely weigh mannose (Man), glucosamine (GlcN), galactosamine (GalN), glucuronic acid (GlcUA), glucose (Glc), galactose (Gal), xylose (Xyl), rock Proper amount of fucose (Fuc), add deionized water to prepare two mixed standard solutions containing the above monosaccharides 0.1mg / mL, ready to use;

[0053] (2) Create an alkaline environment: Take 40μL of mixed monosaccharide standard in a 1.5mL centrifuge tube, add 40μL of 0.3mol / L sodium hydroxide, and vortex to mix;

[0054] (3) PMP derivatization: add 60μL 0.5mol / L 1-phenyl-5-methylpyrazolone (PMP) to each sample, vortex to mix, centrifuge and react in an oven at 70°C for 1h;

[0055] (4) Acid neutralization reaction: take out the samples in the oven, leave them to cool, add 40μL 0.3mol / L hydrochloric acid to each sample, vortex and mix;

[0056] (5) Extraction: add 500μL of chloroform to each tube, vortex, centrifuge, remove the lower layer of chloroform, save the supernatant, repeat 3 times;

[0057]...

Example Embodiment

[0080] Example 2

[0081] (1) Precisely weigh appropriate amounts of mannose (Man), rhamnose (Rha) and glucose (Glc), and add deionized water to prepare the same 5 portions of the same 0.1 mg / mL mixed standard solution containing the above monosaccharides. Match

[0082] (2) Create an alkaline environment: Take 40μL of mixed monosaccharide standard in a 1.5mL centrifuge tube, add 40μL of 0.3mol / L sodium hydroxide, and vortex to mix;

[0083] (3) PMP derivation: add 60μL 0.5mol / L PMP to each sample, vortex to mix, centrifuge and react in an oven at 70°C for 1h;

[0084] (4) Acid neutralization reaction: take out the samples in the oven, leave them to cool, add 40μL 0.3mol / L hydrochloric acid to each sample, vortex and mix;

[0085] (5) Extraction: add 500μL of chloroform to each tube, vortex, centrifuge, remove the lower layer of chloroform, save the supernatant, repeat 3 times;

[0086] (6) Centrifuge the sample at 13000r / min for 10min, take 80μL of supernatant into a brown sample bottl...

Example Embodiment

[0106] Example 3

[0107] (1) Precisely weigh an appropriate amount of mannose and glucose, add deionized water to prepare the above monosaccharides 0.5mg / mL, 0.25mg / mL, 0.1mg / mL, 0.05mg / mL, 0.01mg / mL, 0.005mg / mL, 0.0025mg / mL, 0.001mg / mL, 0.0005mg / mL mixed standard solution, ready to use;

[0108] (2) Create an alkaline environment: Take 40μL of mixed monosaccharide standard in a 1.5mL centrifuge tube, add 40μL of 0.3mol / L sodium hydroxide, and vortex to mix;

[0109] (3) PMP derivation: add 60μL 0.5mol / L PMP to each sample, vortex to mix, centrifuge and react in an oven at 70°C for 1h;

[0110] (4) Acid neutralization reaction: take out the samples in the oven, leave them to cool, add 40μL 0.3mol / L hydrochloric acid to each sample, vortex and mix;

[0111] (5) Extraction: add 500μL of chloroform to each tube, vortex, centrifuge, remove the lower layer of chloroform, save the supernatant, repeat 3 times;

[0112] (6) Centrifuge the sample at 13000 r / min for 10 min, take 80 μL of supern...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Wavelengthaaaaaaaaaa
Bandwidthaaaaaaaaaa
Login to view more

Abstract

The invention provides a method and a detection kit for identifying a biomarker of cerebral hemorrhage. The biomarker is free mannose and glucose obtained by high performance liquid chromatography based on pre-column 1-phenyl-3-methyl-5-pyrazolone (PMP) derivatization in serum. The detection method is the high performance liquid chromatography method based on the pre-column PMP derivatization. Thetechnical scheme has the advantages that the pretreatment is simple, the analysis time is short, the instrument price is reasonable, the requirements of conventional use are met, the operation stepsare simple and easy to learn, and the accuracy of a detection result is high, a normal person and a cerebral hemorrhage patient can be distinguished only by blood collection, the amount of the neededserum is extremely small, the blood collection amount is smaller than 1 mL, and the like. The obtained result shows that the analysis method can be used for rapidly determining the content of the freemannose and glucose in the serum of the cerebral hemorrhage patient, so that the method has very important significance for researching a relation between the free mannose and glucose in the serum and the cerebral hemorrhage, and looking for a novel cerebral hemorrhage clinical detection marker.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a method for identifying biomarkers of cerebral hemorrhage and a detection kit thereof. Background technique [0002] Cerebral hemorrhage refers to hemorrhage caused by non-traumatic vascular rupture in the brain parenchyma, accounting for 20% to 30% of all strokes, and the fatality rate in the acute phase is 30% to 40%. The cause of the occurrence is mainly related to cerebrovascular lesions, that is, closely related to hyperlipidemia, diabetes, high blood pressure, aging of blood vessels, and smoking. Patients with cerebral hemorrhage often develop sudden onset due to emotional agitation and exertion, and have a high early mortality rate. Most of the survivors have sequelae such as motor disorders, cognitive impairments, and speech and swallowing disorders to varying degrees. The diagnosis of cerebral hemorrhage is generally made by head CT examination combined wi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N30/02G01N30/06
CPCG01N30/02G01N30/06G01N2030/067
Inventor 张丽娟张朦张国庆张睿
Owner THE AFFILIATED HOSPITAL OF QINGDAO UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products